|
 The J&J shot, which has not been approved in Japan, will join a list
of three other shots that have been approved by regulators as
sufficient for non-residents to enter, after a nearly two-year ban
on such travellers.
The other approved vaccines on a list that the foreign ministry
released on Thursday are the ones developed by Pfizer Inc, Moderna
Inc, and Astrazeneca Plc.
Vaccines developed by Chinese and Russian makers are not included.
From March 1, authorities will raise the number of people allowed in
to Japan to 5,000 a day, from 3,500, Prime Minister Fumio Kishida
told reporters last week. The easing applies to students, workers,
and other visa holders, but not to tourists for the time being.
[to top of second column] |
 The quarantine period will be reduced to three
days in some conditions, from seven, and it will
be waived entirely depending on the traveller's
point of origin, and if they have had a booster
shot.
(Reporting by Rocky Swift; Editing by Robert
Birsel)
[© 2022 Thomson Reuters. All rights
reserved.] This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |
